Institut NeuroMyoGène, CNRS UMR5310, INSERM U1217, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon I, 8 Avenue Rockefeller, 69373, Lyon Cedex 08, France.
Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan.
Cell Mol Life Sci. 2019 Jul;76(13):2615-2632. doi: 10.1007/s00018-019-03059-8. Epub 2019 Mar 12.
The Tar DNA-Binding Protein 43 (TDP-43) and its phosphorylated isoform (pTDP-43) are the major components associated with ubiquitin positive/Tau-negative inclusions found in neurons and glial cells of patients suffering of amyotrophic lateral sclerosis (ALS) or frontotemporal lobar degeneration-TDP-43 (FTLD-TDP). Many studies have revealed that TDP-43 is also in the protein inclusions associated with neurodegenerative conditions other than ALS and FTLD-TDP, thus suggesting that this protein may be involved in the pathogenesis of a variety of neurological disorders. In brains of Huntington-affected patients, pTDP-43 aggregates were shown to co-localize with mutant Huntingtin (mHtt) inclusions. Here, we show that expression of mHtt carrying 80-97 polyglutamines repeats in human cell cultures induces the aggregation and the phosphorylation of endogenous TDP-43, whereas non-pathological Htt with 25 polyglutamines repeats has no effect. Mutant Htt aggregation precedes accumulation of pTDP-43 and pTDP-43 co-localizes with mHtt inclusions reminding what it was previously described in brains of Huntington-affected patients. Detergent-insoluble fractions from cells expressing mHtt and containing mHtt-pTDP-43 co-aggregates can function as seeds for further TDP-43 aggregation in human cell culture. The human cellular prion protein PrP was previously identified as a negative modulator of mHtt aggregation; here, we show that PrP-mediated reduction of mHtt aggregation is tightly correlated with a decrease of TDP-43 aggregation and phosphorylation, thus confirming the close relationships between TDP-43 and mHtt.
TDP-43 蛋白及其磷酸化异构体(pTDP-43)是与肌萎缩侧索硬化症(ALS)或额颞叶变性-TDP-43(FTLD-TDP)患者神经元和神经胶质细胞中发现的泛素阳性/ Tau 阴性包涵体相关的主要成分。许多研究表明,TDP-43 也存在于除 ALS 和 FTLD-TDP 以外的神经退行性疾病相关的蛋白包涵体中,这表明该蛋白可能参与多种神经疾病的发病机制。在亨廷顿病患者的大脑中,已经表明 pTDP-43 聚集体与突变亨廷顿蛋白(mHtt)包涵体共定位。在这里,我们表明在人细胞培养物中表达携带 80-97 个多聚谷氨酰胺重复的 mHtt 会诱导内源性 TDP-43 的聚集和磷酸化,而具有 25 个多聚谷氨酰胺重复的非病理 Htt 则没有影响。突变 Htt 的聚集先于 pTDP-43 的积累,并且 pTDP-43 与 mHtt 包涵体共定位,这与先前在亨廷顿病患者大脑中描述的情况相似。表达 mHtt 并含有 mHtt-pTDP-43 共聚集物的细胞的去污剂不溶性级分可以作为在人细胞培养物中进一步诱导 TDP-43 聚集的种子。人类朊病毒蛋白 PrP 先前被鉴定为 mHtt 聚集的负调节剂;在这里,我们表明 PrP 介导的 mHtt 聚集减少与 TDP-43 聚集和磷酸化的减少密切相关,从而证实了 TDP-43 和 mHtt 之间的密切关系。